RE: Being held back !4 Jul 2023 10:49
It was made very clear at the AGM that AVCT is now entering a 'commercial phase' however they would not succumb to 'boosting' the SP
I think even the most negative would accept that the science is revolutionary and even at P1a has demonstrated significant commercial value to those who understand (ref Heights investment and over subscribed PI raise)
Therefore, if WYN et al are to be believed it would seem that it is now a straightforward race between further commercialisation and running out of funds.
It has been stated unequivocally by the BOD that they have funds to take AVA6k to completion of P1b AND whilst P1b is running, the company has confirmed that it will produce complete, peer reviewed, findings from P1a which they will then promote to 'mainstream media'
If the results keep coming and exceeding expectations as they have to date, raising funds will absolutely not be a problem regardless of where they are in the development cycle.
The results so far have almost certainly removed any difficulty AVCT will find in raising additional funding from specialist lenders should they need it (to reiterate, they have confirmed they don't need it currently)
The market on the other hand, doesn't understand the science and doesn't have the money, thick as mince.